RhumbLine Advisers’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.5M | Buy |
|
|||||
|
2025
Q2 | $12.5M | Buy |
|
|||||
|
2025
Q1 | $6.02M | Sell |
|
|||||
|
2024
Q4 | $5.62M | Buy |
|
|||||
|
2024
Q3 | $10.4M | Buy |
|
|||||
|
2024
Q2 | $7.18M | Buy |
|
|||||
|
2024
Q1 | $3.39M | Buy |
|
|||||
|
2023
Q4 | $3.6M | Sell |
|
|||||
|
2023
Q3 | $2.55M | Buy |
|
|||||
|
2023
Q2 | $3.82M | Buy |
|
|||||
|
2023
Q1 | $3.21M | Buy |
|
|||||
|
2022
Q4 | $2.47M | Buy |
|
|||||
|
2022
Q3 | $1.51M | Buy |
|
|||||
|
2022
Q2 | $973K | Buy |
|
|||||
|
2022
Q1 | $679K | Buy |
|
|||||
|
2021
Q4 | $452K | Sell |
|
|||||
|
2021
Q3 | $793K | Buy |
|
|||||
|
2021
Q2 | $756K | Sell |
|
|||||
|
2021
Q1 | $973K | Sell |
|
|||||
|
2020
Q4 | $484K | Buy |
|
|||||
|
2020
Q3 | $297K | Buy |
|
|||||
|
2020
Q2 | $382K | Buy |
|
|||||
|
2020
Q1 | $160K | Buy |
|
|||||
|
2019
Q4 | $206K | Buy |
|